An easier time for restricted mobility in HCM patients?

Published Date: 13 Mar 2023

Electrophysiologist John Mandrola, MD. and Rachel Lampert, MD, reviewed the LIVE-HCM study comparing exercise and no exercise in people with hypertrophic cardiomyopathy.

Read Full News

Latest News

Fact vs. Fallacy: Challenging the Norms of Cancer Care

Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.

The Alcohol-Sugar Double Whammy Coming to Patients Near You

Highly sweetened alcoholic drinks may amplify liver risk by combining concentrated alcohol exposure with metabolic stress.

Exam Rooms Front Line in Fight Against Youth Vaping

Exam rooms are becoming a critical and increasingly complex front line in preventing adolescent nicotine addiction.

Occupational PTSD Typically Affects UK Men More Than Women

A 28-year surveillance study in the UK showed that occupational posttraumatic stress disorder most frequently affected men, with police and military personnel at the highest risk.

CAR-T Therapy Shows Promise in CNS and Extramedullary B-ALL

A retrospective study evaluates the effectiveness of CD19 CAR T-cell therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with extramedullary or CNS disease.

Reassuring Data for Two High-Efficacy MS Meds in Pregnancy

Two longitudinal studies showed no adverse safety signals associated with prenatal exposure to two high-efficacy drugs for MS.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Latest News

Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.

Highly sweetened alcoholic drinks may amplify liver risk by combining concentrated alcohol exposure with metabolic stress.

Exam rooms are becoming a critical and increasingly complex front line in preventing adolescent nicotine addiction.

A 28-year surveillance study in the UK showed that occupational posttraumatic stress disorder most frequently affected men, with police and military personnel at the highest risk.

A retrospective study evaluates the effectiveness of CD19 CAR T-cell therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with extramedullary or CNS disease.

Two longitudinal studies showed no adverse safety signals associated with prenatal exposure to two high-efficacy drugs for MS.

News All Time

For Farmers, Mental Health Care That Fits

Two recently launched initiatives endorse ‘farm-informed therapy’ to support mental health in the prairie provinces.

Is Venetoclax Retreatment Effective in Relapsed CLL?

Researchers review available clinical evidence for retreatment with venetoclax, alone or in combination, in patients with relapsed chronic lymphocytic leukemia.

Genetic Testing for Kidney Disease Often Not Discussed

A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet established clinical criteria.

Prenatal Vitamin D Linked to Modest Gains in Child Memory

High-dose vitamin D3 supplementation during pregnancy may improve memory in children.

Is Pregnancy Safe for Women With Myasthenia Gravis?

Pregnancy does not increase the risk for exacerbations of myasthenia gravis, but the postpartum period is associated with a higher risk for prolonged hospital stays for exacerbations.

Docs Say Patients Are Losing Trust in Their Advice: Survey

In a new Medscape survey of 400 US physicians, nearly half said their patients have less trust in their treatment recommendations. See the key findings from the survey.

Don't Blame COVID for Diabetes 'Surge' in Kids

The prevalence of type 2 diabetes is rising among US youth, and if we don’t address the real causes, we really will see a potentially unstoppable surge.

How to Boost CRC Screening Uptake in the Community

Programs that support patients in the screening process or mail stool test kits to their homes are most effective at boosting colorectal cancer screening rates.

Global Outbreaks and Travel Vaccination Update

From rabid seals off South Africa to urban Anopheles stephensi in Africa, shifting vectors and outbreaks mean clinicians must update travel vaccine counseling and pretravel immunization plans.

Endometriosis Linked to Raised Breast & Ovarian Cancer Risks

Women with endometriosis or adenomyosis face a higher risk for breast cancer and ovarian cancer than those without these conditions.

HCV Antiviral Moves Toward EU Use in Acute Infection

European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.

Cataract Surgery: 4 Things You Might Not Know

From mythical thorn bushes to flying aces, the remarkable history of one of medicine’s most routine procedures.

Managing the Second Victim in Healthcare

After a patient safety incident, clinicians need confidential, empathetic, and nonpunitive support — not blame — to prevent burnout and silence, reduce repeat errors, and improve reporting and care quality.

Reduced JAK Inhibitor Dosing May Not Compromise RA Outcomes

In patients with rheumatoid arthritis and preserved kidney function, reduced initial doses of JAK inhibitors show 2-year treatment persistence and disease control similar to those with standard doses.

Tofacitinib May Have Beneficial Effect on JIA Patient Growth

According to a post hoc analysis of patients with juvenile idiopathic arthritis on tofacitinib, younger patients have higher height velocities than expected, and older patients have normal velocities.

What a PA Retirement Wave May Mean for Healthcare Access

As more PAs consider retirement, some areas of the country may face shortages, resulting in worse access to healthcare.

Recommended News For You

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

Stem Cell Selection Unneeded for SSc Transplant Therapy?

In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

New research points out a promising strategy for treating metastatic medulloblastoma

Recommended Articles For You

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care 

Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon  

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment 

Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

T-DXd Reduces Residual Disease in Early Breast Cancer

2.

'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

3.

Additional Proof of the Different Cognitive Effects of ARSIs for Prostate Cancer.

4.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

5.

Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.

1.

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition

2.

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era

3.

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs

4.

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology

5.

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

2.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot